Max Healthcare Institute announced that the Board of Directors of the Company at its meeting held on 22 May 2024, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Max Healthcare Institute rose 0.25% to Rs 251.54 crore in the quarter ended March 2024 as against Rs 250.92 crore during the previous quarter ended March 2023. Sales rose 17.16% to Rs 1422.90 crore in the quarter ended March 2024 as against Rs 1214.51 crore during the previous quarter ended March 2023.For the full year,net profit declined 4.16% to Rs 1057.64 crore in the year ended March 2024 as against Rs 1103.51 crore during the previous year ended March 2023. Sales rose 18.49% to Rs 5406.02 crore in the year ended March 2024 as against Rs 4562.60 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1422.901214.51 17 5406.024562.60 18 OPM %26.8128.02 -27.6027.19 - PBDT406.05361.03 12 1610.301295.91 24 PBT335.73300.68 12 1365.321063.72 28 NP251.54250.92 0 1057.641103.51 -4 Powered by Capital Market - Live News

Max Healthcare Institute has completed the acquisition of 99.90% equity stake in Alexis Multi-Speciality Hospital (Alexis). Consequently, Alexis has become a subsidiary of the Company with effect from 09 February 2024.Powered by Capital Market - Live News

Max Healthcare Institute announced the acquisition of 100% stake in Alexis MultiSpeciality Hospital (Alexis) for an enterprise value of Rs 412 crore.The 200 bedded hospital owned & operated by Alexis is a JCI accredited facility located on a land parcel of ~2 acres at Mankapur, North of Nagpur - an upmarket residential and commercial hub. The hospital has G+6 floors and a basement with built up area of ~2.25 Lakh sft and offers multidisciplinary care in the areas of Gastroenterology, Neurosurgery, Cardiology, Transplants, related diagnostic facilities etc. The hospital is equipped with high end bio medical equipment like Varian True Beam LINAC, 128 Slice CT Scan, 3 Tesla MRI, Digital X Ray, ARTIS Q Cath Lab, etc.The bed capacity can be expanded to ~340 beds in view of the availability of the FAR for the given land and the strength of the existing structure. Further, the hospital medical program can be further strengthened in the surgical specialties like CTVS, Urology, Oncology & Neurosciences leading to improvement in average revenue per occupied bed (ARPOB) and occupied bed days(OBD).The current run rate of Revenue & EBITDA for the Hospital is Rs 150 crore & Rs 25 crroe respectively. The hospital is generating cash & has good brand equity in the market in the region. The cost of acquisition is Rs 372 crore. Powered by Capital Market - Live News

Net profit of Max Healthcare Institute rose 30.09% to Rs 289.34 crore in the quarter ended December 2023 as against Rs 222.41 crore during the previous quarter ended December 2022. Sales rose 16.92% to Rs 1334.97 crore in the quarter ended December 2023 as against Rs 1141.78 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1334.971141.78 17 OPM %28.9027.50 - PBDT420.64338.47 24 PBT359.68281.44 28 NP289.34222.41 30 Powered by Capital Market - Live News